Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05829317
PHASE4

Magnesium Prophylaxis for the Prevention of New-Onset Atrial Fibrillation in Critically Ill Patients

Sponsor: Dr. Stephanie Sibley

View on ClinicalTrials.gov

Summary

A double-blind, multi-centre, randomized, placebo-controlled, feasibility pilot trial in the prevention of new onset atrial fibrillation of critically ill patients admitted to an ICU.

Official title: Parenteral Magnesium Prophylaxis for the Prevention of New-Onset Atrial Fibrillation in Critically Ill Patients - a Pilot Feasibility Study

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

200

Start Date

2023-08-20

Completion Date

2028-07-01

Last Updated

2025-09-22

Healthy Volunteers

No

Interventions

DRUG

Magnesium sulfate

Intravenous Magnesium sulfate

DRUG

Placebo

0.9% NaCl

Locations (4)

St Joseph's Healthcare Hamilton

Hamilton, Ontario, Canada

Kingston Health Sciences Centre

Kingston, Ontario, Canada

The Ottawa Hospital - General Campus

Ottawa, Ontario, Canada

The Ottawa Hospital - Civic Campus

Ottawa, Ontario, Canada